Safety of long‑acting ß2‑agonists: current state of knowledge. Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 2
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 30, 2016
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adrenergic beta-2 Receptor Agonists (MeSH)
- Asthma (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Humans (MeSH)
- Patient Safety (MeSH)